Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative topical NSAIDs and steroids vs steroids alone after corneal endothelial transplantation (DMEK/DSAEK)
2023-510091-31-00Phase 4Authorised
- Sponsor
- Oslo University Hospital
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Fuchs endothelial dystrophy (FED) comparing Topical nepafenac + dexamethasone with Topical dexamethasone alone (2 arms). Primary endpoint: Central macular thickness and macular cysts on optical coherence tomography. Planned start Oct 2024; status: authorised.
02
Drugs
nepafenacHiDex
03
Conditions
Fuchs endothelial dystrophy (FED)
Beyond the preview
Go deeper on 2023-510091-31-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-510091-31-00.